Loading candles…
Bilcare Limited operates in the pharmaceutical packaging and clinical trials industries, specializing in research-driven packaging solutions designed to address challenges such as counterfeit protection, compliance, and dosage stability. The company provides end-to-end services for clinical trial materials primarily through its Global Clinical Supplies (GCS) business segment. Its offerings include pharmaceutical packaging, clinical trials materials, comparator sourcing, primary and secondary packaging, and global logistics. No information is provided regarding the company's incorporation details, founders, key management, subsidiaries, geographic operations, notable projects, or stock exchange listings.
This page is a live market overview for BILCARE LTD. (BI) on the NSE. As a listed security, BILCARE LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BI before placing trades on tick2trade.
As of the latest feed, BI last traded at ₹62.92 on NSE, up ₹1.67 (2.73%) from the previous close of ₹61.25. Today's session range is ₹61.01 – ₹63.5, against a 52-week band of ₹51.62 – ₹75. Traded volume today stands at 5.34K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for BI in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BI is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BILCARE LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BI. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BI option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.